Skip to main content
logo
Synmosa Biopharma Corporation (TPEX:4114)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
35.60
+0.10 (0.28%)
Jul 22, 2025, 9:00 AM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Generic Drugs
4.96B
Log In
Log In
Log In
Log In
Upgrade
Generic Drugs Growth
17.05%
Log In
Log In
Log In
Log In
Upgrade
Active Pharmaceutical Ingredients
179.59M
Log In
Log In
Log In
Log In
Upgrade
Active Pharmaceutical Ingredients Growth
21.37%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Taiwan
4.37B
Log In
Log In
Log In
Log In
Upgrade
Taiwan Growth
12.69%
Log In
Log In
Log In
Log In
Upgrade
China
534.01M
Log In
Log In
Log In
Log In
Upgrade
China Growth
96.52%
Log In
Log In
Log In
Log In
Upgrade
Thailand
54.56M
Log In
Log In
Log In
Log In
Upgrade
Thailand Growth
37.79%
Log In
Log In
Log In
Log In
Upgrade
Singapore
41.91M
Log In
Log In
Log In
Log In
Upgrade
Malaysia
36.45M
Log In
Log In
Log In
Log In
Upgrade
Malaysia Growth
18.54%
Log In
Log In
Log In
Log In
Upgrade
United States
28.78M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-54.12%
Log In
Log In
Log In
Log In
Upgrade
Canada
15.50M
Log In
Log In
Log In
Log In
Upgrade
Canada Growth
-55.68%
Log In
Log In
Log In
Log In
Upgrade
Other
60.80M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-13.28%
Log In
Log In
Log In
Log In
Upgrade